| Document |
Document Title |
|
WO/2019/094517A1 |
Provided are methods of treating urothelial carcinomas of the lower tract comprising administering comprising administering gemcitabine continuously and locally to the bladder of an individual in an induction therapy and/or maintenance t...
|
|
WO/2019/089385A1 |
Methods, devices, and systems establish and facilitate retrograde or reverse flow blood circulation in the region of the carotid artery bifurcation in order to limit or prevent the release of emboli into the cerebral vasculature such as ...
|
|
WO/2019/089537A1 |
Systems, apparatus, and methods are described for delivering a therapeutic substance to a target area within or proximate to a nasal cavity of a subject, including a reservoir configured to contain the therapeutic substance and a deliver...
|
|
WO/2019/089943A1 |
Methods and devices for delivering pancreatic islet function to a body are described where the device may generally comprise at least one port casing configured to be placed subcutaneously within the body. A catheter may be fluidly coupl...
|
|
WO/2019/080647A1 |
Disclosed in the present invention is an eye refractive correction instrument. The eye refractive correction instrument comprises intelligent spectacles, and comprises a microprocessor, a blinking control module, an ocular surface wettin...
|
|
WO/2019/083071A1 |
Provided is a cervical band structure comprising: an elastic body (10); a fixing portion (20) connected to one side of the body and having a plurality of tapered conical structures; a fixing hole (40) arranged at the other side of the bo...
|
|
WO/2019/079384A1 |
Disclosed herein are devices for use in transplanting cells. The devices can include a housing defining a cavity; and a support structure separating the cavity into a cell chamber and a reservoir chamber, wherein the support structure co...
|
|
WO/2019/078756A1 |
This technical solution relates to the field of medicine, more specifically, to the means used in cosmetics and physiotherapy, that is, for the rehabilitation treatment of various non-contagious diseases, and can be used for cosmetic pro...
|
|
WO/2019/071320A1 |
Disclosed herein is an RFID tag insertion cartridge (10) comprising a hollow needle (12) in which an RFID tag is disposed. The cartridge (10) comprises an optional housing (16) in the form of a shell that is shown transparently. The cart...
|
|
WO/2019/068136A1 |
A device and a method for using a device to receive and/or deliver a substance in vivo is disclosed. The device includes a hollow body having a wall that defines an internal volume, wherein the wall comprises at least one opening extendi...
|
|
WO/2019/067536A1 |
A collapsible pessary is provided, and can have a stem and at least one rotating petal member that can rotate between a collapsed state with a smaller diameter and a deployed state with a larger diameter. The collapsible pessary can have...
|
|
WO/2019/058333A2 |
A drug delivery device configured to simultaneously interface with a scala tympani and a scala vestibuli of a cochlea, wherein the device can be configured to deliver drug to the cochlea at least in part via a post introduction non-diffu...
|
|
WO/2019/053466A1 |
The present invention provides a drug composition comprising particles comprising a biodegradable or bioerodable polymer and a drug, a soluble, biodegradable or bioerodible excipient, a bulking agent and a reconstitution aid. The inventi...
|
|
WO/2019/055272A1 |
Devices and methods for delivering fluid to the nasal cavity that include a delivery tube (20) and cap (40) configured to be connected to a container (100) that houses the fluid. The delivery tube (20) includes an inner cannula (31) that...
|
|
WO/2019/056007A1 |
Embodiments provide systems for delivering cosmetic agents (CA) into the skin. The system includes a power source and at least two electrode assemblies (EA) which may be attached or otherwise incorporated into a facemask assembly that fi...
|
|
WO/2019/053465A1 |
The present invention provides a cannulation device for administering an active agent containing composition into the eye. The invention provides methods of treatment of an ocular disease or condition accordingly. The invention also prov...
|
|
WO/2019/052271A1 |
A polar graphene fragment solution for producing a graphene fabric and a preparation method therefor, and a graphene fabric prepared using the polar graphene fragment solution. Graphene molecules in the polar graphene fragment solution r...
|
|
WO/2019/043611A1 |
An intranasal device for weight loss comprises at least one first elastic clip (2) having an inner arm (3) adapted to be inserted in a nasal cavity and at least partially soaked with at least one scented substance or mixture of scented s...
|
|
WO/2019/036363A1 |
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof, such as glatiramer acetate).
|
|
WO/2019/035886A1 |
A medical packing device for use within a body cavity of a subject is provided. The medical packing device comprises an absorbent member having at least a first major side surface and at least one depression that is formed in the first m...
|
|
WO/2019/024726A1 |
Disclosed is a balloon catheter (1000) with a drug coating. The balloon catheter comprises a pushing catheter (310), at least one first balloon (100) with a drug coating, and a sheath (220). The pushing catheter (310) has a proximal end ...
|
|
WO/2019/024765A1 |
Disclosed is a balloon catheter (1000) with a drug coating. The balloon catheter comprises a pushing catheter (310), at least one expandable first balloon (100) located at a distal end of the pushing catheter (310), and a pre-expansion m...
|
|
WO/2019/023218A1 |
A device for the extraction of an analyte from a fecal sample, the device comprising a housing comprising a detachable cap with an integral spatula, within the housing is an extraction buffer that solubilizes feces into a liquid phase an...
|
|
WO/2019/018913A1 |
The invention relates to applicators for dispensing topical products in a single dose on anal, oral, rectal, vaginal and vulvar mucous or semi-mucous membranes. The encasing-type packaging is similar to a sheath, but smaller, having a co...
|
|
WO/2019/023388A1 |
The present invention provides methods for treating or suppressing tumor metastasis at a site distinct from the bladder in an individual having a urothelial carcinoma of lower tract, comprising locally delivering to the bladder an effect...
|
|
WO/2019/020071A1 |
A tapered applicator for a cervix, used for the sampling, wiping, and application of a cervix and secretions thereof, and having a tapered medical foam head and a handle which is mounted vertically on the tapered medical foam head. The t...
|
|
WO/2019/014802A1 |
A liquid-state light transmission device for intervention comprises a catheter (1) provided with a cavity (5) therein. A tail sheath (2) is disposed on one end of the catheter (1), and a liquid-laser coupler (3) capable of injecting a li...
|
|
WO/2019/014800A1 |
A novel fiber optic catheter and a preparation method therefor. A cavity (1) for transmitting a liquid or a gas and a fiber core layer (2) for transmitting light are disposed in the fiber optic catheter. A hemispherical or conical cover ...
|
|
WO/2019/011943A1 |
The invention relates to a chamber (100) for encapsulating secreting cells producing at least one substance of interest, the chamber comprising: - an upper washer (120) and a bottom washer (110) configured to be oppositely placed on a si...
|
|
WO/2019/010281A1 |
This invention provides for a method for improving the success rate of in vitro fertilization in women hosting abnormal vaginal microbiota. The method comprises the steps of: (i) selecting a woman suspected of hosting abnormal vaginal mi...
|
|
WO/2019/005903A1 |
Catheter and catheter assemblies for extracorporeal circulation of body fluids, such as blood, are described. A catheter includes a septum that divides an internal lumen into fluidicly isolated drainage and infusion lumens. The infusion ...
|
|
WO/2018/236104A1 |
A drug delivery robot is provided. The drug delivery robot comprises: a storage space in which a drug is stored; a first accommodation unit formed at the front of the storage space along a first direction; an outlet by which the first ac...
|
|
WO/2018/230577A1 |
The objective of the present invention is to render allogeneic blood transfusion unnecessary in isolated pelvic perfusion in which a medication is administered into a closed pelvis while an amount being infused into an artery is greater ...
|
|
WO/2018/232289A1 |
A diffusing applicator is provided and includes a head unit (10), and extension shaft (20) and a dispensing device (40). The head unit (10) includes a fluid receiving space and a plurality of dispensing passageways in communication the f...
|
|
WO/2018/231801A1 |
A system may include a data processor and a memory storing instructions. The instructions may result in operations when executed by the data processor. The operations may include determining, based on location data from a positioning sys...
|
|
WO/2018/222378A1 |
A multi-lumen catheter for monitoring intrauterine pressure comprising an elongated body configured and dimensioned for insertion into a uterus of a patient, the catheter having a first lumen, a second lumen, and a first balloon at a dis...
|
|
WO/2018/222339A1 |
A carrier device and methods of use, for implanting in biological tissue and releasing a medical payload in the biological tissue according to remote ultrasound trigger pulses. The carrier device includes at least one internal resonant e...
|
|
WO/2018/213588A1 |
Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surfac...
|
|
WO/2018/213582A1 |
Components with relatively high loading of active pharmaceutical ingredients are generally provided. In some embodiments, the component (e.g., a tissue interfacing component) comprises a solid therapeutic agent and a supporting material ...
|
|
WO/2018/213187A1 |
A pessary cover for insertion of a pessary device therein can comprise a body comprising an internal pocket, first and second openings, and a band. The internal pocket can be configured to receive a portion of the pessary device. The fir...
|
|
WO/2018/209271A1 |
A probe may be inserted into a body cavity to perform diagnostic intervention(s), therapeutic intervention(s), or both. The probe may be inserted through a body aperture that is naturally occurring or man-made, intentionally or by accide...
|
|
WO/2018/199929A1 |
A prosthetic implant transfer device is provided that may be used to insert a prosthetic implant through a surgical opening. In some embodiments, the device may comprise a flexible sheet of material that may be formed into an elongated h...
|
|
WO/2018/196040A1 |
An expansion suppository body for the vagina. The expansion suppository body can expand in an aqueous solution according to a predetermined value; the expansion value of the expansion suppository body upon absorbing water to saturation i...
|
|
WO/2018/195346A1 |
A drug delivery device with removable pods is described and related pods methods and systems. The drug delivery device comprises a plurality of receptacles, each receptacle configured to accept a corresponding drug pod, wherein each rece...
|
|
WO/2018/195484A1 |
This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis. An implant is configured to fit inside of the middle meatus of a human nasal cavity. The implant includes a therapeu...
|
|
WO/2018/187657A2 |
A device for stopping bleeding from inside a nostril of a human nose. The device being formed from a sponge-like material that has an upper portion having a size and shape adapted for insertion into the nostril of a human nose and the up...
|
|
WO/2018/182641A1 |
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-13 inhibitor. An embodiment of the disclosure relates to releasing the IL- 13 inhibitor at a location in the gastrointestina...
|
|
WO/2018/182612A1 |
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a stem cell.
|
|
WO/2018/183929A1 |
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immune modulatory agent (e.g., a CD40/CD40L inhibitor).
|
|
WO/2018/176526A1 |
A time reversal technique-based system and method for manipulating particles, the goal being the implementation of arbitrary path manipulation with respect to particles in an inhomogeneous medium. The time reversal technique-based system...
|
